Global Vaccin Antirabic Market Research Report 2025(Status and Outlook)
Report Overview
The market for rabies vaccines (Vaccin Antirabic) is driven by the global need to prevent rabies, a fatal viral disease transmitted through animal bites, primarily dogs. The vaccine is essential for both pre-exposure prophylaxis (PrEP) for high-risk groups like veterinarians and travelers, and post-exposure prophylaxis (PEP) for bite victims. Demand is influenced by government immunization programs, rising pet ownership, and increasing awareness in developing regions where rabies remains endemic. The market includes both human and veterinary vaccines, with key players like Sanofi Pasteur, Novartis, and Bharat Biotech dominating production. Emerging economies in Asia and Africa present growth opportunities due to expanding healthcare infrastructure and public health initiatives, though cost and accessibility challenges persist in rural areas. Innovations in cell-based and recombinant vaccines are shaping future market trends.
The global Vaccin Antirabic market size was estimated at USD 407.95 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.25% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Vaccin Antirabic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Vaccin Antirabic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Vaccin Antirabic market.
Global Vaccin Antirabic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GSK
Sanofi
Chengda
Yisheng
Merck
VACN
Changsheng
BCHT
Hissen
Zhongke Biological
Ningbo Rongan Biological Pharmaceutical
Guangzhou Nuocheng Biological
Market Segmentation (by Type)
Gopher Kidney Cell Vaccine
Freeze-Dried Vero Cell Vaccine
Common Vero Cell Vaccines
Human Diploid Vaccine
Market Segmentation (by Application)
Pre-exposure Prophylaxis
After Exposure Prophylaxis
Additional Doses
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Vaccin Antirabic Market
Overview of the regional outlook of the Vaccin Antirabic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccin Antirabic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Vaccin Antirabic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The market for rabies vaccines (Vaccin Antirabic) is driven by the global need to prevent rabies, a fatal viral disease transmitted through animal bites, primarily dogs. The vaccine is essential for both pre-exposure prophylaxis (PrEP) for high-risk groups like veterinarians and travelers, and post-exposure prophylaxis (PEP) for bite victims. Demand is influenced by government immunization programs, rising pet ownership, and increasing awareness in developing regions where rabies remains endemic. The market includes both human and veterinary vaccines, with key players like Sanofi Pasteur, Novartis, and Bharat Biotech dominating production. Emerging economies in Asia and Africa present growth opportunities due to expanding healthcare infrastructure and public health initiatives, though cost and accessibility challenges persist in rural areas. Innovations in cell-based and recombinant vaccines are shaping future market trends.
The global Vaccin Antirabic market size was estimated at USD 407.95 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.25% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Vaccin Antirabic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Vaccin Antirabic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Vaccin Antirabic market.
Global Vaccin Antirabic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GSK
Sanofi
Chengda
Yisheng
Merck
VACN
Changsheng
BCHT
Hissen
Zhongke Biological
Ningbo Rongan Biological Pharmaceutical
Guangzhou Nuocheng Biological
Market Segmentation (by Type)
Gopher Kidney Cell Vaccine
Freeze-Dried Vero Cell Vaccine
Common Vero Cell Vaccines
Human Diploid Vaccine
Market Segmentation (by Application)
Pre-exposure Prophylaxis
After Exposure Prophylaxis
Additional Doses
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Vaccin Antirabic Market
Overview of the regional outlook of the Vaccin Antirabic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccin Antirabic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Vaccin Antirabic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Vaccin Antirabic
1.2 Key Market Segments
1.2.1 Vaccin Antirabic Segment by Type
1.2.2 Vaccin Antirabic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VACCIN ANTIRABIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaccin Antirabic Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Vaccin Antirabic Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VACCIN ANTIRABIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Vaccin Antirabic Product Life Cycle
3.3 Global Vaccin Antirabic Sales by Manufacturers (2020-2025)
3.4 Global Vaccin Antirabic Revenue Market Share by Manufacturers (2020-2025)
3.5 Vaccin Antirabic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Vaccin Antirabic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Vaccin Antirabic Market Competitive Situation and Trends
3.8.1 Vaccin Antirabic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Vaccin Antirabic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VACCIN ANTIRABIC INDUSTRY CHAIN ANALYSIS
4.1 Vaccin Antirabic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VACCIN ANTIRABIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Vaccin Antirabic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Vaccin Antirabic Market
5.7 ESG Ratings of Leading Companies
6 VACCIN ANTIRABIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccin Antirabic Sales Market Share by Type (2020-2025)
6.3 Global Vaccin Antirabic Market Size Market Share by Type (2020-2025)
6.4 Global Vaccin Antirabic Price by Type (2020-2025)
7 VACCIN ANTIRABIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccin Antirabic Market Sales by Application (2020-2025)
7.3 Global Vaccin Antirabic Market Size (M USD) by Application (2020-2025)
7.4 Global Vaccin Antirabic Sales Growth Rate by Application (2020-2025)
8 VACCIN ANTIRABIC MARKET SALES BY REGION
8.1 Global Vaccin Antirabic Sales by Region
8.1.1 Global Vaccin Antirabic Sales by Region
8.1.2 Global Vaccin Antirabic Sales Market Share by Region
8.2 Global Vaccin Antirabic Market Size by Region
8.2.1 Global Vaccin Antirabic Market Size by Region
8.2.2 Global Vaccin Antirabic Market Size Market Share by Region
8.3 North America
8.3.1 North America Vaccin Antirabic Sales by Country
8.3.2 North America Vaccin Antirabic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Vaccin Antirabic Sales by Country
8.4.2 Europe Vaccin Antirabic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Vaccin Antirabic Sales by Region
8.5.2 Asia Pacific Vaccin Antirabic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Vaccin Antirabic Sales by Country
8.6.2 South America Vaccin Antirabic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Vaccin Antirabic Sales by Region
8.7.2 Middle East and Africa Vaccin Antirabic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VACCIN ANTIRABIC MARKET PRODUCTION BY REGION
9.1 Global Production of Vaccin Antirabic by Region(2020-2025)
9.2 Global Vaccin Antirabic Revenue Market Share by Region (2020-2025)
9.3 Global Vaccin Antirabic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Vaccin Antirabic Production
9.4.1 North America Vaccin Antirabic Production Growth Rate (2020-2025)
9.4.2 North America Vaccin Antirabic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Vaccin Antirabic Production
9.5.1 Europe Vaccin Antirabic Production Growth Rate (2020-2025)
9.5.2 Europe Vaccin Antirabic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Vaccin Antirabic Production (2020-2025)
9.6.1 Japan Vaccin Antirabic Production Growth Rate (2020-2025)
9.6.2 Japan Vaccin Antirabic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Vaccin Antirabic Production (2020-2025)
9.7.1 China Vaccin Antirabic Production Growth Rate (2020-2025)
9.7.2 China Vaccin Antirabic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GSK
10.1.1 GSK Basic Information
10.1.2 GSK Vaccin Antirabic Product Overview
10.1.3 GSK Vaccin Antirabic Product Market Performance
10.1.4 GSK Business Overview
10.1.5 GSK SWOT Analysis
10.1.6 GSK Recent Developments
10.2 Sanofi
10.2.1 Sanofi Basic Information
10.2.2 Sanofi Vaccin Antirabic Product Overview
10.2.3 Sanofi Vaccin Antirabic Product Market Performance
10.2.4 Sanofi Business Overview
10.2.5 Sanofi SWOT Analysis
10.2.6 Sanofi Recent Developments
10.3 Chengda
10.3.1 Chengda Basic Information
10.3.2 Chengda Vaccin Antirabic Product Overview
10.3.3 Chengda Vaccin Antirabic Product Market Performance
10.3.4 Chengda Business Overview
10.3.5 Chengda SWOT Analysis
10.3.6 Chengda Recent Developments
10.4 Yisheng
10.4.1 Yisheng Basic Information
10.4.2 Yisheng Vaccin Antirabic Product Overview
10.4.3 Yisheng Vaccin Antirabic Product Market Performance
10.4.4 Yisheng Business Overview
10.4.5 Yisheng Recent Developments
10.5 Merck
10.5.1 Merck Basic Information
10.5.2 Merck Vaccin Antirabic Product Overview
10.5.3 Merck Vaccin Antirabic Product Market Performance
10.5.4 Merck Business Overview
10.5.5 Merck Recent Developments
10.6 VACN
10.6.1 VACN Basic Information
10.6.2 VACN Vaccin Antirabic Product Overview
10.6.3 VACN Vaccin Antirabic Product Market Performance
10.6.4 VACN Business Overview
10.6.5 VACN Recent Developments
10.7 Changsheng
10.7.1 Changsheng Basic Information
10.7.2 Changsheng Vaccin Antirabic Product Overview
10.7.3 Changsheng Vaccin Antirabic Product Market Performance
10.7.4 Changsheng Business Overview
10.7.5 Changsheng Recent Developments
10.8 BCHT
10.8.1 BCHT Basic Information
10.8.2 BCHT Vaccin Antirabic Product Overview
10.8.3 BCHT Vaccin Antirabic Product Market Performance
10.8.4 BCHT Business Overview
10.8.5 BCHT Recent Developments
10.9 Hissen
10.9.1 Hissen Basic Information
10.9.2 Hissen Vaccin Antirabic Product Overview
10.9.3 Hissen Vaccin Antirabic Product Market Performance
10.9.4 Hissen Business Overview
10.9.5 Hissen Recent Developments
10.10 Zhongke Biological
10.10.1 Zhongke Biological Basic Information
10.10.2 Zhongke Biological Vaccin Antirabic Product Overview
10.10.3 Zhongke Biological Vaccin Antirabic Product Market Performance
10.10.4 Zhongke Biological Business Overview
10.10.5 Zhongke Biological Recent Developments
10.11 Ningbo Rongan Biological Pharmaceutical
10.11.1 Ningbo Rongan Biological Pharmaceutical Basic Information
10.11.2 Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Product Overview
10.11.3 Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Product Market Performance
10.11.4 Ningbo Rongan Biological Pharmaceutical Business Overview
10.11.5 Ningbo Rongan Biological Pharmaceutical Recent Developments
10.12 Guangzhou Nuocheng Biological
10.12.1 Guangzhou Nuocheng Biological Basic Information
10.12.2 Guangzhou Nuocheng Biological Vaccin Antirabic Product Overview
10.12.3 Guangzhou Nuocheng Biological Vaccin Antirabic Product Market Performance
10.12.4 Guangzhou Nuocheng Biological Business Overview
10.12.5 Guangzhou Nuocheng Biological Recent Developments
11 VACCIN ANTIRABIC MARKET FORECAST BY REGION
11.1 Global Vaccin Antirabic Market Size Forecast
11.2 Global Vaccin Antirabic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Vaccin Antirabic Market Size Forecast by Country
11.2.3 Asia Pacific Vaccin Antirabic Market Size Forecast by Region
11.2.4 South America Vaccin Antirabic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Vaccin Antirabic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Vaccin Antirabic Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Vaccin Antirabic by Type (2026-2033)
12.1.2 Global Vaccin Antirabic Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Vaccin Antirabic by Type (2026-2033)
12.2 Global Vaccin Antirabic Market Forecast by Application (2026-2033)
12.2.1 Global Vaccin Antirabic Sales (K MT) Forecast by Application
12.2.2 Global Vaccin Antirabic Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Vaccin Antirabic
1.2 Key Market Segments
1.2.1 Vaccin Antirabic Segment by Type
1.2.2 Vaccin Antirabic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VACCIN ANTIRABIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaccin Antirabic Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Vaccin Antirabic Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VACCIN ANTIRABIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Vaccin Antirabic Product Life Cycle
3.3 Global Vaccin Antirabic Sales by Manufacturers (2020-2025)
3.4 Global Vaccin Antirabic Revenue Market Share by Manufacturers (2020-2025)
3.5 Vaccin Antirabic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Vaccin Antirabic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Vaccin Antirabic Market Competitive Situation and Trends
3.8.1 Vaccin Antirabic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Vaccin Antirabic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VACCIN ANTIRABIC INDUSTRY CHAIN ANALYSIS
4.1 Vaccin Antirabic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VACCIN ANTIRABIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Vaccin Antirabic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Vaccin Antirabic Market
5.7 ESG Ratings of Leading Companies
6 VACCIN ANTIRABIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccin Antirabic Sales Market Share by Type (2020-2025)
6.3 Global Vaccin Antirabic Market Size Market Share by Type (2020-2025)
6.4 Global Vaccin Antirabic Price by Type (2020-2025)
7 VACCIN ANTIRABIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccin Antirabic Market Sales by Application (2020-2025)
7.3 Global Vaccin Antirabic Market Size (M USD) by Application (2020-2025)
7.4 Global Vaccin Antirabic Sales Growth Rate by Application (2020-2025)
8 VACCIN ANTIRABIC MARKET SALES BY REGION
8.1 Global Vaccin Antirabic Sales by Region
8.1.1 Global Vaccin Antirabic Sales by Region
8.1.2 Global Vaccin Antirabic Sales Market Share by Region
8.2 Global Vaccin Antirabic Market Size by Region
8.2.1 Global Vaccin Antirabic Market Size by Region
8.2.2 Global Vaccin Antirabic Market Size Market Share by Region
8.3 North America
8.3.1 North America Vaccin Antirabic Sales by Country
8.3.2 North America Vaccin Antirabic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Vaccin Antirabic Sales by Country
8.4.2 Europe Vaccin Antirabic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Vaccin Antirabic Sales by Region
8.5.2 Asia Pacific Vaccin Antirabic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Vaccin Antirabic Sales by Country
8.6.2 South America Vaccin Antirabic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Vaccin Antirabic Sales by Region
8.7.2 Middle East and Africa Vaccin Antirabic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VACCIN ANTIRABIC MARKET PRODUCTION BY REGION
9.1 Global Production of Vaccin Antirabic by Region(2020-2025)
9.2 Global Vaccin Antirabic Revenue Market Share by Region (2020-2025)
9.3 Global Vaccin Antirabic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Vaccin Antirabic Production
9.4.1 North America Vaccin Antirabic Production Growth Rate (2020-2025)
9.4.2 North America Vaccin Antirabic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Vaccin Antirabic Production
9.5.1 Europe Vaccin Antirabic Production Growth Rate (2020-2025)
9.5.2 Europe Vaccin Antirabic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Vaccin Antirabic Production (2020-2025)
9.6.1 Japan Vaccin Antirabic Production Growth Rate (2020-2025)
9.6.2 Japan Vaccin Antirabic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Vaccin Antirabic Production (2020-2025)
9.7.1 China Vaccin Antirabic Production Growth Rate (2020-2025)
9.7.2 China Vaccin Antirabic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GSK
10.1.1 GSK Basic Information
10.1.2 GSK Vaccin Antirabic Product Overview
10.1.3 GSK Vaccin Antirabic Product Market Performance
10.1.4 GSK Business Overview
10.1.5 GSK SWOT Analysis
10.1.6 GSK Recent Developments
10.2 Sanofi
10.2.1 Sanofi Basic Information
10.2.2 Sanofi Vaccin Antirabic Product Overview
10.2.3 Sanofi Vaccin Antirabic Product Market Performance
10.2.4 Sanofi Business Overview
10.2.5 Sanofi SWOT Analysis
10.2.6 Sanofi Recent Developments
10.3 Chengda
10.3.1 Chengda Basic Information
10.3.2 Chengda Vaccin Antirabic Product Overview
10.3.3 Chengda Vaccin Antirabic Product Market Performance
10.3.4 Chengda Business Overview
10.3.5 Chengda SWOT Analysis
10.3.6 Chengda Recent Developments
10.4 Yisheng
10.4.1 Yisheng Basic Information
10.4.2 Yisheng Vaccin Antirabic Product Overview
10.4.3 Yisheng Vaccin Antirabic Product Market Performance
10.4.4 Yisheng Business Overview
10.4.5 Yisheng Recent Developments
10.5 Merck
10.5.1 Merck Basic Information
10.5.2 Merck Vaccin Antirabic Product Overview
10.5.3 Merck Vaccin Antirabic Product Market Performance
10.5.4 Merck Business Overview
10.5.5 Merck Recent Developments
10.6 VACN
10.6.1 VACN Basic Information
10.6.2 VACN Vaccin Antirabic Product Overview
10.6.3 VACN Vaccin Antirabic Product Market Performance
10.6.4 VACN Business Overview
10.6.5 VACN Recent Developments
10.7 Changsheng
10.7.1 Changsheng Basic Information
10.7.2 Changsheng Vaccin Antirabic Product Overview
10.7.3 Changsheng Vaccin Antirabic Product Market Performance
10.7.4 Changsheng Business Overview
10.7.5 Changsheng Recent Developments
10.8 BCHT
10.8.1 BCHT Basic Information
10.8.2 BCHT Vaccin Antirabic Product Overview
10.8.3 BCHT Vaccin Antirabic Product Market Performance
10.8.4 BCHT Business Overview
10.8.5 BCHT Recent Developments
10.9 Hissen
10.9.1 Hissen Basic Information
10.9.2 Hissen Vaccin Antirabic Product Overview
10.9.3 Hissen Vaccin Antirabic Product Market Performance
10.9.4 Hissen Business Overview
10.9.5 Hissen Recent Developments
10.10 Zhongke Biological
10.10.1 Zhongke Biological Basic Information
10.10.2 Zhongke Biological Vaccin Antirabic Product Overview
10.10.3 Zhongke Biological Vaccin Antirabic Product Market Performance
10.10.4 Zhongke Biological Business Overview
10.10.5 Zhongke Biological Recent Developments
10.11 Ningbo Rongan Biological Pharmaceutical
10.11.1 Ningbo Rongan Biological Pharmaceutical Basic Information
10.11.2 Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Product Overview
10.11.3 Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Product Market Performance
10.11.4 Ningbo Rongan Biological Pharmaceutical Business Overview
10.11.5 Ningbo Rongan Biological Pharmaceutical Recent Developments
10.12 Guangzhou Nuocheng Biological
10.12.1 Guangzhou Nuocheng Biological Basic Information
10.12.2 Guangzhou Nuocheng Biological Vaccin Antirabic Product Overview
10.12.3 Guangzhou Nuocheng Biological Vaccin Antirabic Product Market Performance
10.12.4 Guangzhou Nuocheng Biological Business Overview
10.12.5 Guangzhou Nuocheng Biological Recent Developments
11 VACCIN ANTIRABIC MARKET FORECAST BY REGION
11.1 Global Vaccin Antirabic Market Size Forecast
11.2 Global Vaccin Antirabic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Vaccin Antirabic Market Size Forecast by Country
11.2.3 Asia Pacific Vaccin Antirabic Market Size Forecast by Region
11.2.4 South America Vaccin Antirabic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Vaccin Antirabic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Vaccin Antirabic Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Vaccin Antirabic by Type (2026-2033)
12.1.2 Global Vaccin Antirabic Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Vaccin Antirabic by Type (2026-2033)
12.2 Global Vaccin Antirabic Market Forecast by Application (2026-2033)
12.2.1 Global Vaccin Antirabic Sales (K MT) Forecast by Application
12.2.2 Global Vaccin Antirabic Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Vaccin Antirabic Market Size Comparison by Region (M USD)
Table 5. Global Vaccin Antirabic Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Vaccin Antirabic Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Vaccin Antirabic Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Vaccin Antirabic Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccin Antirabic as of 2024)
Table 10. Global Market Vaccin Antirabic Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Vaccin Antirabic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Vaccin Antirabic Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Vaccin Antirabic Sales by Type (K MT)
Table 26. Global Vaccin Antirabic Market Size by Type (M USD)
Table 27. Global Vaccin Antirabic Sales (K MT) by Type (2020-2025)
Table 28. Global Vaccin Antirabic Sales Market Share by Type (2020-2025)
Table 29. Global Vaccin Antirabic Market Size (M USD) by Type (2020-2025)
Table 30. Global Vaccin Antirabic Market Size Share by Type (2020-2025)
Table 31. Global Vaccin Antirabic Price (USD/KG) by Type (2020-2025)
Table 32. Global Vaccin Antirabic Sales (K MT) by Application
Table 33. Global Vaccin Antirabic Market Size by Application
Table 34. Global Vaccin Antirabic Sales by Application (2020-2025) & (K MT)
Table 35. Global Vaccin Antirabic Sales Market Share by Application (2020-2025)
Table 36. Global Vaccin Antirabic Market Size by Application (2020-2025) & (M USD)
Table 37. Global Vaccin Antirabic Market Share by Application (2020-2025)
Table 38. Global Vaccin Antirabic Sales Growth Rate by Application (2020-2025)
Table 39. Global Vaccin Antirabic Sales by Region (2020-2025) & (K MT)
Table 40. Global Vaccin Antirabic Sales Market Share by Region (2020-2025)
Table 41. Global Vaccin Antirabic Market Size by Region (2020-2025) & (M USD)
Table 42. Global Vaccin Antirabic Market Size Market Share by Region (2020-2025)
Table 43. North America Vaccin Antirabic Sales by Country (2020-2025) & (K MT)
Table 44. North America Vaccin Antirabic Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Vaccin Antirabic Sales by Country (2020-2025) & (K MT)
Table 46. Europe Vaccin Antirabic Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Vaccin Antirabic Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Vaccin Antirabic Market Size by Region (2020-2025) & (M USD)
Table 49. South America Vaccin Antirabic Sales by Country (2020-2025) & (K MT)
Table 50. South America Vaccin Antirabic Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Vaccin Antirabic Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Vaccin Antirabic Market Size by Region (2020-2025) & (M USD)
Table 53. Global Vaccin Antirabic Production (K MT) by Region(2020-2025)
Table 54. Global Vaccin Antirabic Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Vaccin Antirabic Revenue Market Share by Region (2020-2025)
Table 56. Global Vaccin Antirabic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Vaccin Antirabic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Vaccin Antirabic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Vaccin Antirabic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Vaccin Antirabic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. GSK Basic Information
Table 62. GSK Vaccin Antirabic Product Overview
Table 63. GSK Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. GSK Business Overview
Table 65. GSK SWOT Analysis
Table 66. GSK Recent Developments
Table 67. Sanofi Basic Information
Table 68. Sanofi Vaccin Antirabic Product Overview
Table 69. Sanofi Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Sanofi Business Overview
Table 71. Sanofi SWOT Analysis
Table 72. Sanofi Recent Developments
Table 73. Chengda Basic Information
Table 74. Chengda Vaccin Antirabic Product Overview
Table 75. Chengda Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Chengda Business Overview
Table 77. Chengda SWOT Analysis
Table 78. Chengda Recent Developments
Table 79. Yisheng Basic Information
Table 80. Yisheng Vaccin Antirabic Product Overview
Table 81. Yisheng Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Yisheng Business Overview
Table 83. Yisheng Recent Developments
Table 84. Merck Basic Information
Table 85. Merck Vaccin Antirabic Product Overview
Table 86. Merck Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Merck Business Overview
Table 88. Merck Recent Developments
Table 89. VACN Basic Information
Table 90. VACN Vaccin Antirabic Product Overview
Table 91. VACN Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. VACN Business Overview
Table 93. VACN Recent Developments
Table 94. Changsheng Basic Information
Table 95. Changsheng Vaccin Antirabic Product Overview
Table 96. Changsheng Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Changsheng Business Overview
Table 98. Changsheng Recent Developments
Table 99. BCHT Basic Information
Table 100. BCHT Vaccin Antirabic Product Overview
Table 101. BCHT Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. BCHT Business Overview
Table 103. BCHT Recent Developments
Table 104. Hissen Basic Information
Table 105. Hissen Vaccin Antirabic Product Overview
Table 106. Hissen Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Hissen Business Overview
Table 108. Hissen Recent Developments
Table 109. Zhongke Biological Basic Information
Table 110. Zhongke Biological Vaccin Antirabic Product Overview
Table 111. Zhongke Biological Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Zhongke Biological Business Overview
Table 113. Zhongke Biological Recent Developments
Table 114. Ningbo Rongan Biological Pharmaceutical Basic Information
Table 115. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Product Overview
Table 116. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Ningbo Rongan Biological Pharmaceutical Business Overview
Table 118. Ningbo Rongan Biological Pharmaceutical Recent Developments
Table 119. Guangzhou Nuocheng Biological Basic Information
Table 120. Guangzhou Nuocheng Biological Vaccin Antirabic Product Overview
Table 121. Guangzhou Nuocheng Biological Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Guangzhou Nuocheng Biological Business Overview
Table 123. Guangzhou Nuocheng Biological Recent Developments
Table 124. Global Vaccin Antirabic Sales Forecast by Region (2026-2033) & (K MT)
Table 125. Global Vaccin Antirabic Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Vaccin Antirabic Sales Forecast by Country (2026-2033) & (K MT)
Table 127. North America Vaccin Antirabic Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Vaccin Antirabic Sales Forecast by Country (2026-2033) & (K MT)
Table 129. Europe Vaccin Antirabic Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Vaccin Antirabic Sales Forecast by Region (2026-2033) & (K MT)
Table 131. Asia Pacific Vaccin Antirabic Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Vaccin Antirabic Sales Forecast by Country (2026-2033) & (K MT)
Table 133. South America Vaccin Antirabic Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Vaccin Antirabic Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Vaccin Antirabic Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Vaccin Antirabic Sales Forecast by Type (2026-2033) & (K MT)
Table 137. Global Vaccin Antirabic Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Vaccin Antirabic Price Forecast by Type (2026-2033) & (USD/KG)
Table 139. Global Vaccin Antirabic Sales (K MT) Forecast by Application (2026-2033)
Table 140. Global Vaccin Antirabic Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Vaccin Antirabic Market Size Comparison by Region (M USD)
Table 5. Global Vaccin Antirabic Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Vaccin Antirabic Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Vaccin Antirabic Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Vaccin Antirabic Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccin Antirabic as of 2024)
Table 10. Global Market Vaccin Antirabic Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Vaccin Antirabic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Vaccin Antirabic Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Vaccin Antirabic Sales by Type (K MT)
Table 26. Global Vaccin Antirabic Market Size by Type (M USD)
Table 27. Global Vaccin Antirabic Sales (K MT) by Type (2020-2025)
Table 28. Global Vaccin Antirabic Sales Market Share by Type (2020-2025)
Table 29. Global Vaccin Antirabic Market Size (M USD) by Type (2020-2025)
Table 30. Global Vaccin Antirabic Market Size Share by Type (2020-2025)
Table 31. Global Vaccin Antirabic Price (USD/KG) by Type (2020-2025)
Table 32. Global Vaccin Antirabic Sales (K MT) by Application
Table 33. Global Vaccin Antirabic Market Size by Application
Table 34. Global Vaccin Antirabic Sales by Application (2020-2025) & (K MT)
Table 35. Global Vaccin Antirabic Sales Market Share by Application (2020-2025)
Table 36. Global Vaccin Antirabic Market Size by Application (2020-2025) & (M USD)
Table 37. Global Vaccin Antirabic Market Share by Application (2020-2025)
Table 38. Global Vaccin Antirabic Sales Growth Rate by Application (2020-2025)
Table 39. Global Vaccin Antirabic Sales by Region (2020-2025) & (K MT)
Table 40. Global Vaccin Antirabic Sales Market Share by Region (2020-2025)
Table 41. Global Vaccin Antirabic Market Size by Region (2020-2025) & (M USD)
Table 42. Global Vaccin Antirabic Market Size Market Share by Region (2020-2025)
Table 43. North America Vaccin Antirabic Sales by Country (2020-2025) & (K MT)
Table 44. North America Vaccin Antirabic Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Vaccin Antirabic Sales by Country (2020-2025) & (K MT)
Table 46. Europe Vaccin Antirabic Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Vaccin Antirabic Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Vaccin Antirabic Market Size by Region (2020-2025) & (M USD)
Table 49. South America Vaccin Antirabic Sales by Country (2020-2025) & (K MT)
Table 50. South America Vaccin Antirabic Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Vaccin Antirabic Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Vaccin Antirabic Market Size by Region (2020-2025) & (M USD)
Table 53. Global Vaccin Antirabic Production (K MT) by Region(2020-2025)
Table 54. Global Vaccin Antirabic Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Vaccin Antirabic Revenue Market Share by Region (2020-2025)
Table 56. Global Vaccin Antirabic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Vaccin Antirabic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Vaccin Antirabic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Vaccin Antirabic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Vaccin Antirabic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. GSK Basic Information
Table 62. GSK Vaccin Antirabic Product Overview
Table 63. GSK Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. GSK Business Overview
Table 65. GSK SWOT Analysis
Table 66. GSK Recent Developments
Table 67. Sanofi Basic Information
Table 68. Sanofi Vaccin Antirabic Product Overview
Table 69. Sanofi Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Sanofi Business Overview
Table 71. Sanofi SWOT Analysis
Table 72. Sanofi Recent Developments
Table 73. Chengda Basic Information
Table 74. Chengda Vaccin Antirabic Product Overview
Table 75. Chengda Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Chengda Business Overview
Table 77. Chengda SWOT Analysis
Table 78. Chengda Recent Developments
Table 79. Yisheng Basic Information
Table 80. Yisheng Vaccin Antirabic Product Overview
Table 81. Yisheng Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Yisheng Business Overview
Table 83. Yisheng Recent Developments
Table 84. Merck Basic Information
Table 85. Merck Vaccin Antirabic Product Overview
Table 86. Merck Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Merck Business Overview
Table 88. Merck Recent Developments
Table 89. VACN Basic Information
Table 90. VACN Vaccin Antirabic Product Overview
Table 91. VACN Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. VACN Business Overview
Table 93. VACN Recent Developments
Table 94. Changsheng Basic Information
Table 95. Changsheng Vaccin Antirabic Product Overview
Table 96. Changsheng Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Changsheng Business Overview
Table 98. Changsheng Recent Developments
Table 99. BCHT Basic Information
Table 100. BCHT Vaccin Antirabic Product Overview
Table 101. BCHT Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. BCHT Business Overview
Table 103. BCHT Recent Developments
Table 104. Hissen Basic Information
Table 105. Hissen Vaccin Antirabic Product Overview
Table 106. Hissen Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Hissen Business Overview
Table 108. Hissen Recent Developments
Table 109. Zhongke Biological Basic Information
Table 110. Zhongke Biological Vaccin Antirabic Product Overview
Table 111. Zhongke Biological Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Zhongke Biological Business Overview
Table 113. Zhongke Biological Recent Developments
Table 114. Ningbo Rongan Biological Pharmaceutical Basic Information
Table 115. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Product Overview
Table 116. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Ningbo Rongan Biological Pharmaceutical Business Overview
Table 118. Ningbo Rongan Biological Pharmaceutical Recent Developments
Table 119. Guangzhou Nuocheng Biological Basic Information
Table 120. Guangzhou Nuocheng Biological Vaccin Antirabic Product Overview
Table 121. Guangzhou Nuocheng Biological Vaccin Antirabic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Guangzhou Nuocheng Biological Business Overview
Table 123. Guangzhou Nuocheng Biological Recent Developments
Table 124. Global Vaccin Antirabic Sales Forecast by Region (2026-2033) & (K MT)
Table 125. Global Vaccin Antirabic Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Vaccin Antirabic Sales Forecast by Country (2026-2033) & (K MT)
Table 127. North America Vaccin Antirabic Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Vaccin Antirabic Sales Forecast by Country (2026-2033) & (K MT)
Table 129. Europe Vaccin Antirabic Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Vaccin Antirabic Sales Forecast by Region (2026-2033) & (K MT)
Table 131. Asia Pacific Vaccin Antirabic Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Vaccin Antirabic Sales Forecast by Country (2026-2033) & (K MT)
Table 133. South America Vaccin Antirabic Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Vaccin Antirabic Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Vaccin Antirabic Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Vaccin Antirabic Sales Forecast by Type (2026-2033) & (K MT)
Table 137. Global Vaccin Antirabic Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Vaccin Antirabic Price Forecast by Type (2026-2033) & (USD/KG)
Table 139. Global Vaccin Antirabic Sales (K MT) Forecast by Application (2026-2033)
Table 140. Global Vaccin Antirabic Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Vaccin Antirabic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaccin Antirabic Market Size (M USD), 2024-2033
Figure 5. Global Vaccin Antirabic Market Size (M USD) (2020-2033)
Figure 6. Global Vaccin Antirabic Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaccin Antirabic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Vaccin Antirabic Product Life Cycle
Figure 13. Vaccin Antirabic Sales Share by Manufacturers in 2024
Figure 14. Global Vaccin Antirabic Revenue Share by Manufacturers in 2024
Figure 15. Vaccin Antirabic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Vaccin Antirabic Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Vaccin Antirabic Revenue in 2024
Figure 18. Industry Chain Map of Vaccin Antirabic
Figure 19. Global Vaccin Antirabic Market PEST Analysis
Figure 20. Global Vaccin Antirabic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Vaccin Antirabic Market Share by Type
Figure 27. Sales Market Share of Vaccin Antirabic by Type (2020-2025)
Figure 28. Sales Market Share of Vaccin Antirabic by Type in 2024
Figure 29. Market Size Share of Vaccin Antirabic by Type (2020-2025)
Figure 30. Market Size Share of Vaccin Antirabic by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Vaccin Antirabic Market Share by Application
Figure 33. Global Vaccin Antirabic Sales Market Share by Application (2020-2025)
Figure 34. Global Vaccin Antirabic Sales Market Share by Application in 2024
Figure 35. Global Vaccin Antirabic Market Share by Application (2020-2025)
Figure 36. Global Vaccin Antirabic Market Share by Application in 2024
Figure 37. Global Vaccin Antirabic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Vaccin Antirabic Sales Market Share by Region (2020-2025)
Figure 39. Global Vaccin Antirabic Market Size Market Share by Region (2020-2025)
Figure 40. North America Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Vaccin Antirabic Sales Market Share by Country in 2024
Figure 43. North America Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Vaccin Antirabic Market Size Market Share by Country in 2024
Figure 45. U.S. Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Vaccin Antirabic Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Vaccin Antirabic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Vaccin Antirabic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Vaccin Antirabic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Vaccin Antirabic Sales Market Share by Country in 2024
Figure 53. Europe Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Vaccin Antirabic Market Size Market Share by Country in 2024
Figure 55. Germany Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Vaccin Antirabic Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Vaccin Antirabic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Vaccin Antirabic Market Size Market Share by Region in 2024
Figure 68. China Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Vaccin Antirabic Sales and Growth Rate (K MT)
Figure 79. South America Vaccin Antirabic Sales Market Share by Country in 2024
Figure 80. South America Vaccin Antirabic Market Size and Growth Rate (M USD)
Figure 81. South America Vaccin Antirabic Market Size Market Share by Country in 2024
Figure 82. Brazil Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Vaccin Antirabic Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Vaccin Antirabic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Vaccin Antirabic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Vaccin Antirabic Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Vaccin Antirabic Production Market Share by Region (2020-2025)
Figure 103. North America Vaccin Antirabic Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Vaccin Antirabic Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Vaccin Antirabic Production (K MT) Growth Rate (2020-2025)
Figure 106. China Vaccin Antirabic Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Vaccin Antirabic Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Vaccin Antirabic Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Vaccin Antirabic Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Vaccin Antirabic Market Share Forecast by Type (2026-2033)
Figure 111. Global Vaccin Antirabic Sales Forecast by Application (2026-2033)
Figure 112. Global Vaccin Antirabic Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Vaccin Antirabic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaccin Antirabic Market Size (M USD), 2024-2033
Figure 5. Global Vaccin Antirabic Market Size (M USD) (2020-2033)
Figure 6. Global Vaccin Antirabic Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaccin Antirabic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Vaccin Antirabic Product Life Cycle
Figure 13. Vaccin Antirabic Sales Share by Manufacturers in 2024
Figure 14. Global Vaccin Antirabic Revenue Share by Manufacturers in 2024
Figure 15. Vaccin Antirabic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Vaccin Antirabic Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Vaccin Antirabic Revenue in 2024
Figure 18. Industry Chain Map of Vaccin Antirabic
Figure 19. Global Vaccin Antirabic Market PEST Analysis
Figure 20. Global Vaccin Antirabic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Vaccin Antirabic Market Share by Type
Figure 27. Sales Market Share of Vaccin Antirabic by Type (2020-2025)
Figure 28. Sales Market Share of Vaccin Antirabic by Type in 2024
Figure 29. Market Size Share of Vaccin Antirabic by Type (2020-2025)
Figure 30. Market Size Share of Vaccin Antirabic by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Vaccin Antirabic Market Share by Application
Figure 33. Global Vaccin Antirabic Sales Market Share by Application (2020-2025)
Figure 34. Global Vaccin Antirabic Sales Market Share by Application in 2024
Figure 35. Global Vaccin Antirabic Market Share by Application (2020-2025)
Figure 36. Global Vaccin Antirabic Market Share by Application in 2024
Figure 37. Global Vaccin Antirabic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Vaccin Antirabic Sales Market Share by Region (2020-2025)
Figure 39. Global Vaccin Antirabic Market Size Market Share by Region (2020-2025)
Figure 40. North America Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Vaccin Antirabic Sales Market Share by Country in 2024
Figure 43. North America Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Vaccin Antirabic Market Size Market Share by Country in 2024
Figure 45. U.S. Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Vaccin Antirabic Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Vaccin Antirabic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Vaccin Antirabic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Vaccin Antirabic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Vaccin Antirabic Sales Market Share by Country in 2024
Figure 53. Europe Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Vaccin Antirabic Market Size Market Share by Country in 2024
Figure 55. Germany Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Vaccin Antirabic Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Vaccin Antirabic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Vaccin Antirabic Market Size Market Share by Region in 2024
Figure 68. China Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Vaccin Antirabic Sales and Growth Rate (K MT)
Figure 79. South America Vaccin Antirabic Sales Market Share by Country in 2024
Figure 80. South America Vaccin Antirabic Market Size and Growth Rate (M USD)
Figure 81. South America Vaccin Antirabic Market Size Market Share by Country in 2024
Figure 82. Brazil Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Vaccin Antirabic Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Vaccin Antirabic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Vaccin Antirabic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Vaccin Antirabic Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Vaccin Antirabic Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Vaccin Antirabic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Vaccin Antirabic Production Market Share by Region (2020-2025)
Figure 103. North America Vaccin Antirabic Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Vaccin Antirabic Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Vaccin Antirabic Production (K MT) Growth Rate (2020-2025)
Figure 106. China Vaccin Antirabic Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Vaccin Antirabic Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Vaccin Antirabic Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Vaccin Antirabic Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Vaccin Antirabic Market Share Forecast by Type (2026-2033)
Figure 111. Global Vaccin Antirabic Sales Forecast by Application (2026-2033)
Figure 112. Global Vaccin Antirabic Market Share Forecast by Application (2026-2033)
More Publications
Global Tocotrienols Supplements Market Research Report 2025(Status and Outlook)
US$ 3,200.00
September 2025
139 pages
Global Penicillamine Market Research Report 2026(Status and Outlook)
US$ 3,200.00
May 2026
129 pages
Global Cad Cam Dental Milling Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
164 pages
Global Rosuvastatin Market Research Report 2025(Status and Outlook)
US$ 3,200.00
February 2025
214 pages
Global COVID-19 Antibody Detection Kits Market Research Report 2025(Status and Outlook)
US$ 3,200.00
July 2025
166 pages
